| # | Side effect | Count |
|---|---|---|
| 0 | DRUG INEFFECTIVE | 113 |
| 1 | OFF LABEL USE | 77 |
| 2 | DEATH | 76 |
| 3 | HYPOTHYROIDISM | 75 |
| 4 | HYPERTRIGLYCERIDAEMIA | 59 |
| 5 | DISEASE PROGRESSION | 58 |
| 6 | FATIGUE | 50 |
| 7 | PRURITUS | 47 |
| 8 | MALIGNANT NEOPLASM PROGRESSION | 43 |
| 9 | CONDITION AGGRAVATED | 39 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | CUTANEOUS T-CELL LYMPHOMA REFRACTORY | 7 | 0.3333 |
| 1 | CUTANEOUS T-CELL LYMPHOMA STAGE I | 9 | 0.2500 |
| 2 | SEZARY CELLS INCREASED | 2 | 0.2500 |
| 3 | THYROID STIMULATING HORMONE DEFICIENCY | 8 | 0.2424 |
| 4 | REGIONAL CHEMOTHERAPY | 1 | 0.1667 |
| 5 | MYCOSIS FUNGOIDES REFRACTORY | 1 | 0.1667 |
| 6 | CONJUNCTIVAL PRIMARY ACQUIRED MELANOSIS | 1 | 0.1250 |
| 7 | CUTANEOUS T-CELL LYMPHOMA RECURRENT | 7 | 0.1111 |
| 8 | CUTANEOUS T-CELL LYMPHOMA STAGE II | 2 | 0.0909 |
| 9 | CUTANEOUS T-CELL LYMPHOMA STAGE IV | 3 | 0.0833 |